Browsing Tag
Jay Bradner
4 posts
Novartis to acquire Cadent Therapeutics in $770m deal to bolster neuropsychiatric pipeline
Find out how Novartis plans to transform neuroscience with its $770M acquisition of Cadent Therapeutics and its novel CNS treatment pipeline.
Novartis acquires Vedere Bio to advance optogenetic gene therapy for vision restoration
In a significant acquisition that could reshape the landscape of gene therapy for vision restoration, Swiss pharmaceutical giant…
Novartis to acquire IFM Tre with eye on immunomodulatory drugs
Novartis acquisition of IFM Tre : Novartis has signed a deal worth up to $1.575 billion to acquire…
Blackstone Life Sciences and Novartis launch Anthos Therapeutics to target high-risk cardiovascular diseases
In a strategic partnership aimed at advancing cardiovascular treatments, Blackstone Life Sciences has teamed up with Swiss pharmaceutical…